Essen University Hospital is a pace setter for first-rate medical services in the Ruhr metropolis. Here, scientific research is tightly interwoven with medical practice, directly benefitting patients who can be certain that they will receive the latest available therapies. In clinical trials, they receive innovative treatments from which patients elsewhere will not benefit until many years later once they become standard therapies everywhere. Every year, about 195,000 outpatients and 53,000 inpatients are treated here. With its many top modern clinics, nearly three miles of roads, and 54 acres of land, the University Hospital is almost like a small city within the city. And it is one of the biggest employers of the region: more than 6,000 people work here in many different professions, from physicians, scientists, nurses and physiotherapists, to engineers and chefs. The Essen University Hospital offers medical care with state-of-the art diagnostics and therapies that live up to the highest international standards. Its focus is on five major areas of research and treatment: cardiovascular disease, cancer, transplants, immunology and infectiology, as well as translational neuroscience and behavioural sciences.

The Department of Neurology at the University Hospital Essen combines clinical skills with modern diagnostic and treatment options and innovative clinical or pre-clinical research. The clinic has 66 beds including a stroke unit and a section for neurologic intensive care and is treating patients from a large part of Germany. More than 50 specialized physicians take care of patients with neurologic diseases, with a focus on stroke, multiple sclerosis, polyneuropathies, pain and headache. The department of neurology is conducting large and small clinical trials, like the PRO DAST study including Stroke and TIA patients. Together with the Centre for Clinical Studies (ZKSE) an immense knowledge of human study design and execution is given. Within the University Hospital Essen, the NeuroScienceLab is doing research on neurovascular diseases. A main focus is on translational stroke research, both clinical and pre-clinical. The definitive goal of the NeuroScienceLab is, to find biomarkers and new therapies to improve stroke prevention and outcome.